Bipsync, a research automation platform that maximizes the productivity and efficiency of investment professionals, today announces the availability of its Open Beta for individuals and early access to its Enterprise product for buyside investment teams. The company also confirms the close of its $1.5 million seed financing, raised from a mix of well-known angel investors, individual buyside professionals investing their private capital, and a venture capital firm. Select investors include: Russell Siegelman (Stanford Lecturer and Partner Emeritus, Kleiner Perkins Caufield & Byers), David Eisner (Founder of themarkets.com), and Steadfast Venture Capital.

'Thirty percent of our seed round funding came from individual investment professionals - end users investing their own private capital,' says Danny Donado, Bipsync Founder and CEO. 'For a product-driven company, there's no better validation than delighted customers wanting to invest. We're humbled by their support and thrilled today to share what we have been building with a wider audience.'

Research Automation for Modern Investment Teams
Investment management firms have always faced a difficult choice between intuitive-but-risky consumer software or safe-but-confusing enterprise software. Bipsync bridges the gap, meeting the technical demands of the enterprise with the familiarity of popular consumer software.

'The IT security and compliance requirements are beyond anything consumer-focused software hosted on the public cloud can provide. At the same time, traditional financial software is notoriously complex and clunky,' explains Donado, a former hedge fund analyst. 'Amazingly, this means that a personal investor using a patchwork of easy-to-use productivity software like Evernote and Dropbox is better equipped than a professional investment analyst. That ends today.'

Individual investors and small teams up to three can now sign up for immediate access to the free Open Beta - bringing unprecedented accessibility to research management and automation technology.

Using Bipsync's Open Beta, investors can easily:

Capture: The fastest, most efficient digital notebook for investors
Organize: Slice and dice research across multiple dimensions
Collaborate: Auto-map personal organization to collective knowledge
Measure: Analytics, reports and visualizations on your research assets and pipeline
In addition to opening up the service, Bipsync also announced two commercial tiers for larger investment teams with enhanced functionality such as multi-team support, advanced access control, compliance automations, advanced data management, administrative capabilities, support and more. Most importantly, both commercial tiers are private installations. Bipsync partnered with five sizable hedge funds - collectively managing over $20 billion in assets - to gather feedback for its closed Enterprise Beta. The company's commitment to product design, open access and transparent pricing runs contrast to the sales-driven, blackbox approach that still dominates the investment software industry.

The 'Fund' tier starts at $3,000/month per firm and includes 5 seats, while the 'Enterprise' tier starts at $10,000/month per firm and includes 20 seats. Investors can secure early access pricing of $2,000/month and $7,500/month for the 'Fund' and 'Enterprise' tiers respectively through January 31, 2015.

Automate your research in minutes with Bipsync technology by signing up at: https://app.bipsync.com/signup

About Bipsync
Bipsync provides a research automation platform to maximize the productivity of professional investors. Founded in Silicon Valley in 2012 by experienced investors and software developers at Stanford University, the company uses modern technologies and user-centered design to speed up data capture, automate research maintenance and identify insights that drive better decisions for investors and funds.